A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.

MLA

Lee, Jacob, et al. “A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.” Journal of Korean Medical Science, vol. 34, no. 4, Jan. 2019, p. e31. EBSCOhost, https://doi.org/10.3346/jkms.2019.34.e31.

APA

Lee, J., Choi, J.-H., Wie, S.-H., Park, S. H., Choi, S.-M., Lee, M. S., Kim, T. H., Lee, H.-J., & Kang, J. H. (2019). A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults. Journal of Korean Medical Science, 34(4), e31. https://doi.org/10.3346/jkms.2019.34.e31

Chicago

Lee, Jacob, Jung-Hyun Choi, Seong-Heon Wie, Sun Hee Park, Su-Mi Choi, Mi Suk Lee, Tae Hyong Kim, Hyo-Jin Lee, and Jin Han Kang. 2019. “A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.” Journal of Korean Medical Science 34 (4): e31. doi:10.3346/jkms.2019.34.e31.